 Ironwood Pharmaceuticals, Inc. NASDAQ: IRWD announced today that the United States Patent and Trademark Office USPTO has issued Notices of Allowance for patent applications covering the formulation of the 72 mcg dose of LINZESS linaclotide and methods of using the formulation. The patent applications 